Statement of Thailand to EB 126 (Jan 2010) on public health, innovation and intellectual property

The following statement was delivered by Thailand on Tuesday, 19 January 2010 during the discussion of agenda item 4.3 on public health, innovation and intellectual property. This statement requested Dr. Chan (Director-General, WHO) to conduct an investigation of the leaks of documents of the WHO Expert Working Group on R&D Financing to the IFPMA. In its statement, Thailand noted that the circle of trust had been broken.

Mr. Chairman,

I thank Madame DG to her explanation about the process and documentations including her constructive advices

PhRMA Special 301 submission on Thailand

The following discusses the 2009 PhRMA submission for the USTR Special 301 list on Thailand. Thailand is one of three Asian countries (China, Philippines and Thailand) that were singled out by PhRMA for the harshest treatment. The submission on Thailand covers several topics, including these:

KEI Letter to Thailand Prime Minister and Health Minister, regarding compulsory licensing decisions

His Excellency
Mr. Samak Sundaravej
Prime Minister
Government House
Nakornpratom Rd.
Dusit, Bangkok
Thailand 10300

His Excellency
Mr. Chaiya Sasomsap
Minister of Public Health
Tiwanont Rd.
Talad Kwan District
Nontaburi Province 11000

March 4, 2008

Re: Thailand Compulsory Licenses and public health

Dear Prime Minister Sundaravej and Minister of Public Health Chaiya Sasomsap:

Thailand - Selected News Stories

September 5, 2007. David Cronin for Intellectual Property Watch.  EU Split Over Thai Effort to Obtain Cheapter Patented Drugs.

July 24, 2007. Bangkok Post. Thai Activists Attack Drug Ban.

Thailand's Compulsory Licensing Controversy

Between November 2006 and January 2007, Thailand issued compulsory licenses for two AIDS drugs (efavirnz and the combination of lopinavir+ritonavir) and one antihypertension drug (clopidegrel).  The pharmaceutical industry has vehemently objected to these compulsory licenses, and has sought the US government's assistance in the matter.  Though USTR  has been careful not to claim that the Thai government has violated the TRIPS Agreement, it did place Thailand on the 301 Report's Priority Watch List.  Currently, the Thai government is in the process of deciding whe

KEI Statement on USTR 301 list reference to Thailand

Monday, 30 April 2007

"The sanctioning of countries for using legitimate and important flexibilities in the TRIPS agreement brings shame to all U.S. citizens who are increasingly seen in Thailand and elsewhere as bullies and hypocrites." 

KEI Statement on USTR 301 list reference to Thailand

Knowledge Ecology International - KEI Statement on USTR 301 list reference to Thailand
KEI Statement on USTR 301 list reference to Thailand
Syndicate content